Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.10.07.680974

Bone conducted responses using the parallel auditory brainstem response (pABR) paradigm

Polonenko, M. J.·Maddox, R. K.
View original source ↗Export metadata ↓

Abstract

ObjectivesAuditory brainstem responses (ABRs) are used to diagnose hearing loss across multiple frequencies in infants and others who cannot participate in behavioral testing. The parallel ABR (pABR) paradigm measures response waveforms to all frequencies from 500- 8000 Hz in both ears all at once, rather than serially in one ear at a time. Work so far has been with air conducted stimuli through insert earphones, but bone conducted stimuli are also an essential part of diagnosing the type of hearing loss by determining the relative contributions of conductive and sensorineural hearing loss. This study aimed to confirm the feasibility of bone conduction pABR. DesignWe recruited a cohort of young adults with normal hearing. An intensity series of two-channel ABRs were measured to pABR stimuli played through ER-2 insert earphones as well as with a B-71 bone vibrator with contralateral masking. Behavioral thresholds were also measured to compare dB nHL correction factors. To keep sessions under 3.5 hours only one ear was tested with bone conduction. The ear with bone conduction and the order of transducers was counterbalanced across participants. Waveform morphologies for each transducer were compared by their wave V latencies and amplitudes and residual noise. ResultsFor the same dB nHL levels, responses to both transducers aligned well and wave V amplitudes and latencies were similar. While stimulus artifacts can be an issue with bone conduction, the steps taken to mitigate it in air conduction pABR were also effective for bone conduction: clear bone conducted responses were measured and residual noise was similar for both transducers. Bone conducted responses to 8 kHz were weak, which was not surprising given the physics of bone conduction and the output capabilities of the bone vibrator. As expected, behavioral thresholds were higher for pABR than pure tone stimuli, and by the same offset for both transducers. The dB nHL values differed due to the difference in reference equivalent threshold levels for inserts and the bone vibrator. ConclusionsAir and bone conduction provided similar waveforms, indicating that bone conduction pABR is feasible. Together with establishing dB nHL values, this work represents an important step towards translating the pABR for diagnosing all types of hearing loss.

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Polonenko, M. J., Maddox, R. K.. 2025-10-07. Bone conducted responses using the parallel auditory brainstem response (pABR) paradigm. https://doi.org/10.1101/2025.10.07.680974

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗